Tumor Antigen CTAA16.88 (Votumumab biosimilar) Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-Tumor Antigen CTAA16.88 (Votumumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityTumor Antigen CTAA16.88 (Votumumab biosimilar)
Clonemonoclonal
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG3 kappa
FormatProtein A purified
Size100 µg, 1 mg,
Concentration1 mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis product is for research use only (RUO) by laboratories. It is not suitable for use in humans or as a medicine. Votumumab is a Human monoclonal antibody targeting Tumor Antigen CTAA16.88, expressed in Mammalian cells.
Immunogenn/a
Other NamesVotumumab, Tumor Antigen CTAA16.88, Carcinoma associated antigen CTAA16 (complex of cytokeratin polypeptides - 35-40kDa)
Gene, Accession #n/a
Catalog #abx832504
Priceplease inquire
Order / More InfoTumor Antigen CTAA16.88 (Votumumab biosimilar) Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.